当前位置:首页 - 行情中心 - 科华生物(002022) - 财务分析 - 现金流量表

科华生物

(002022)

  

流通市值:30.80亿  总市值:30.81亿
流通股本:5.14亿   总股本:5.14亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,375,566,176.82873,716,596.44414,395,641.312,074,536,262.26
  收到的税费返还889,009.85582,838.46348,998.275,697,500.85
  收到其他与经营活动有关的现金32,114,681.5631,080,860.913,362,362.6983,130,454.1
  经营活动现金流入小计1,408,569,868.23905,380,295.8428,107,002.272,163,364,217.21
  购买商品、接受劳务支付的现金743,388,116.94477,104,365.73223,814,645.441,224,140,126.69
  支付给职工以及为职工支付的现金384,225,815.11280,221,819.99157,413,514.31543,915,765.68
  支付的各项税费43,000,398.0130,728,130.118,530,639.5692,435,429.27
  支付其他与经营活动有关的现金262,052,519.52168,322,620.6979,640,184.75352,988,895.24
  经营活动现金流出小计1,432,666,849.58956,376,936.51479,398,984.062,213,480,216.88
  经营活动产生的现金流量净额-24,096,981.35-50,996,640.71-51,291,981.79-50,115,999.67
二、投资活动产生的现金流量:
  收回投资收到的现金---315,000,000
  取得投资收益收到的现金1,354,770.8950,951.51410,373.812,917,113.31
  处置固定资产、无形资产和其他长期资产收回的现金净额4,954,381.534,099,439.372,549,733.896,273,720.2
  处置子公司及其他营业单位收到的现金净额1,000,000100,000--
  投资活动现金流入小计7,309,152.335,150,390.882,960,107.69334,190,833.51
  购建固定资产、无形资产和其他长期资产支付的现金96,368,018.8365,131,594.2232,066,928.81254,819,904.18
  投资支付的现金---3,500,000
  投资活动现金流出小计96,368,018.8365,131,594.2232,066,928.81258,319,904.18
  投资活动产生的现金流量净额-89,058,866.5-59,981,203.34-29,106,821.1275,870,929.33
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,250,000--2,786,095
  其中:子公司吸收少数股东投资收到的现金2,250,000--2,786,095
  取得借款收到的现金378,539,640.48295,372,654.86110,663,735.31399,781,366.71
  收到其他与筹资活动有关的现金---6,132,655.75
  筹资活动现金流入小计380,789,640.48295,372,654.86110,663,735.31408,700,117.46
  偿还债务支付的现金187,953,239.02172,555,251.8263,765,647.44871,542,039.95
  分配股利、利润或偿付利息支付的现金61,444,204.7454,741,780.0844,613,568.6269,842,043.71
  其中:子公司支付给少数股东的股利、利润50,197,00050,197,00042,849,00045,400,000
  支付其他与筹资活动有关的现金10,222,073.815,721,059.421,879,360.45241,461,176.73
  筹资活动现金流出小计259,619,517.57233,018,091.32110,258,576.511,182,845,260.39
  筹资活动产生的现金流量净额121,170,122.9162,354,563.54405,158.8-774,145,142.93
四、汇率变动对现金及现金等价物的影响-606,958.05584,918.122,676,669.893,155,507.38
五、现金及现金等价物净增加额7,407,317.01-48,038,362.39-77,316,974.22-745,234,705.89
  加:期初现金及现金等价物余额860,377,257.92860,377,257.92864,626,234.891,605,611,963.81
  期末现金及现金等价物余额867,784,574.93812,338,895.53787,309,260.67860,377,257.92
补充资料:
  净利润--140,116,685.34--730,647,366.78
  资产减值准备-21,392,766.4-225,183,072.01
  固定资产和投资性房地产折旧-61,815,708.79-138,713,344
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-61,815,708.79-138,713,344
  无形资产摊销-32,137,203.58-82,431,117.44
  长期待摊费用摊销-6,778,662.34-12,851,391.51
  处置固定资产、无形资产和其他长期资产的损失--2,344,755.76--4,208,562.56
  固定资产报废损失-352,271.69-3,342,366.79
  公允价值变动损失-19,103.55-1,172,720.33
  财务费用-5,930,458.53-41,369,106.13
  投资损失--715,257.64--11,973,131.52
  递延所得税--1,051,316.64--17,331,913.64
  其中:递延所得税资产减少--504,950.21--7,585,820.58
    递延所得税负债增加--546,366.43--9,746,093.06
  存货的减少-41,234,982.33--34,886,039.52
  经营性应收项目的减少-37,451,874.2-105,030,870.57
  经营性应付项目的增加--137,559,322.84--80,236,692.38
  现金的期末余额-812,338,895.53-860,377,257.92
  减:现金的期初余额-860,377,257.92-1,605,611,963.81
  现金及现金等价物的净增加额--48,038,362.39--745,234,705.89
公告日期2025-10-302025-08-272025-04-302025-04-28
审计意见(境内)标准无保留意见
TOP↑